60,036 Shares of Schrodinger, Inc. $SDGR Bought by Calamos Advisors LLC

Calamos Advisors LLC acquired a new stake in shares of Schrodinger, Inc. (NASDAQ:SDGR) during the 3rd quarter, Holdings Channel.com reports. The fund acquired 60,036 shares of the company’s stock, valued at approximately $1,864,000.

Several other institutional investors and hedge funds have also recently bought and sold shares of the company. Root Financial Partners LLC bought a new position in Schrodinger during the 3rd quarter worth approximately $50,000. Sterling Capital Management LLC increased its holdings in shares of Schrodinger by 843.8% in the 3rd quarter. Sterling Capital Management LLC now owns 1,916 shares of the company’s stock valued at $59,000 after acquiring an additional 1,713 shares during the last quarter. Allworth Financial LP bought a new stake in shares of Schrodinger in the 2nd quarter valued at approximately $86,000. PNC Financial Services Group Inc. increased its holdings in shares of Schrodinger by 1,037.1% in the 1st quarter. PNC Financial Services Group Inc. now owns 7,778 shares of the company’s stock valued at $88,000 after acquiring an additional 7,094 shares during the last quarter. Finally, Integrated Wealth Concepts LLC bought a new stake in shares of Schrodinger in the 2nd quarter valued at approximately $102,000. Institutional investors and hedge funds own 79.05% of the company’s stock.

Insider Activity at Schrodinger

In other news, insider Karen Akinsanya sold 31,599 shares of the stock in a transaction that occurred on Thursday, September 17th. The stock was sold at an average price of $29.37, for a total transaction of $928,062.63. Following the sale, the insider directly owned 69,956 shares in the company, valued at approximately $2,054,607.72. This represents a 31.12% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Company insiders own 10.10% of the company’s stock.

Schrodinger Stock Up 12.0%

SDGR opened at $33.39 on Tuesday. The firm has a market cap of $2.46 billion, a price-to-earnings ratio of -42.27 and a beta of 1.69. Schrodinger, Inc. has a fifty-two week low of $10.94 and a fifty-two week high of $33.78. The company’s 50-day moving average price is $26.07 and its 200 day moving average price is $17.16.

Schrodinger (NASDAQ:SDGR) last issued its earnings results on Wednesday, November 4th. The company reported ($0.50) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.67) by $0.17. Schrodinger had a negative net margin of 22.02% and a negative return on equity of 17.66%. The firm had revenue of $64.49 million for the quarter, compared to analysts’ expectations of $47.73 million. During the same quarter last year, the company posted ($0.45) earnings per share. Schrodinger’s revenue was up 18.7% on a year-over-year basis. Research analysts anticipate that Schrodinger, Inc. will post -1.39 earnings per share for the current year.

Analyst Upgrades and Downgrades

SDGR has been the topic of several research reports. Weiss Ratings raised Schrodinger from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Thursday, August 27th. BMO Capital Markets lifted their price objective on shares of Schrodinger from $24.00 to $30.00 and gave the stock an “outperform” rating in a report on Monday, October 12th. Wall Street Zen raised shares of Schrodinger from a “strong sell” rating to a “hold” rating in a report on Saturday, August 8th. UBS Group boosted their target price on shares of Schrodinger from $19.00 to $21.00 and gave the company a “neutral” rating in a research note on Tuesday, October 20th. Finally, TD Cowen increased their target price on shares of Schrodinger from $31.00 to $36.00 and gave the stock a “buy” rating in a report on Thursday, November 5th. Four equities research analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $26.67.

Schrodinger Profile

Schrödinger, Inc develops computational software used to support drug discovery and materials research. Its platform applies physics-based modeling, computational chemistry and machine learning to help researchers analyze molecular properties and identify promising candidates. The company’s tools are used by pharmaceutical and biotechnology companies, academic institutions and other research organizations.

Alongside software sales and subscriptions, Schrödinger works with partners on drug discovery programs and advances a portfolio of its own therapeutic candidates.